847 related articles for article (PubMed ID: 7863543)
1. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
2. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
3. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes.
Dyson PJ; Knight AM; Fairchild S; Simpson E; Tomonari K
Nature; 1991 Feb; 349(6309):531-2. PubMed ID: 1846950
[TBL] [Abstract][Full Text] [Related]
4. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
Foo-Phillips M; Kozak CA; Principato MA; Abe R
J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
[TBL] [Abstract][Full Text] [Related]
6. Physiologic expression of two superantigens in the BDF1 mouse.
Gollob KJ; Palmer E
J Immunol; 1991 Oct; 147(8):2447-54. PubMed ID: 1655891
[TBL] [Abstract][Full Text] [Related]
7. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
Abe R; Foo-Phillips M; Granger LG; Kanagawa O
J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
[TBL] [Abstract][Full Text] [Related]
9. Differences in the avidity of TCR interactions with a superantigenic ligand affect negative selection but do not allow positive selection.
Chervonsky AV; Golovkina TV; Ross SR; Janeway CA
J Immunol; 1995 Dec; 155(11):5115-23. PubMed ID: 7594520
[TBL] [Abstract][Full Text] [Related]
10. Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice.
Zhou P; Anderson GD; Savarirayan S; Inoko H; David CS
J Immunol; 1991 Feb; 146(3):854-9. PubMed ID: 1899097
[TBL] [Abstract][Full Text] [Related]
11. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
Tucek CL; Desaymard C; Papiernik M
J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Mtv loci in MHC class II-positive thymic stromal cells.
Moore NC; Anderson G; McLoughlin DE; Owen JJ; Jenkinson EJ
J Immunol; 1994 May; 152(10):4826-31. PubMed ID: 8176205
[TBL] [Abstract][Full Text] [Related]
13. The influence of self-MHC and non-MHC antigens on the selection of an antigen-specific T cell receptor repertoire.
Fry AM; Cotterman MM; Matis LA
J Immunol; 1989 Oct; 143(8):2723-9. PubMed ID: 2477456
[TBL] [Abstract][Full Text] [Related]
14. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
Borrero H; Collazo L; Macphail S
Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
[TBL] [Abstract][Full Text] [Related]
15. MHC bias of Mls-1 recognition is not influenced by thymic positive selection.
Nguyen P; Woodland DL; Blackman MA
Cell Immunol; 1996 Feb; 167(2):224-9. PubMed ID: 8603431
[TBL] [Abstract][Full Text] [Related]
16. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA
J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
[TBL] [Abstract][Full Text] [Related]
18. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
Anderson GD; Banerjee S; Luthra HS; David CS
J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
[TBL] [Abstract][Full Text] [Related]
19. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
20. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]